Nonmetabolic Complications of Continuous Subcutaneous Insulin Infusion: A Patient Survey

Insulin-Pump Therapy for Type 1 Diabetes Mellitus

(2012) John C. Pickup   NEW ENGLAND JOURNAL OF MEDICINE

The Role of Basal Insulin and Glucagon-Like Peptide-1 Agonists in the Therapeutic Management of Type 2 Diabetes—A Comprehensive Review

(2010) Satish K. Garg   Diabetes Technology & Therapeutics

Comparison of Pharmacokinetic Properties, Physicochemical Stability, and Pump Compatibility of 3 Rapid-Acting Insulin Analogues-Aspart, Lispro, and Glulisine

(2010) Bruce Bode   Endocrine Practice

Insulin Pump Therapy Guidelines for Successful Outcomes

(2009) Gary Scheiner et al.   DIABETES EDUCATOR

Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy

(2009) Daniela Bruttomesso et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007

(2009) I. Guilhem et al.   DIABETOLOGIA

Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion

(2009) Tina K. Thethi et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Severe hypoglycaemia and glycaemic control in Type1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

(2008) J. C. Pickup et al.   DIABETIC MEDICINE

Dermatological Complications of Continuous Subcutaneous Insulin Infusion in Children and Adolescents

(2008) Louise S. Conwell et al.   JOURNAL OF PEDIATRICS

Adolescent Use of Insulin and Patient-Controlled Analgesia Pump Technology: A 10-Year Food and Drug Administration Retrospective Study of Adverse Events

(2008) J. U. Cope et al.   PEDIATRICS